These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 10813370)

  • 1. Crataegus special extract WS 1442 increases force of contraction in human myocardium cAMP-independently.
    Schwinger RH; Pietsch M; Frank K; Brixius K
    J Cardiovasc Pharmacol; 2000 May; 35(5):700-7. PubMed ID: 10813370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence for a sustained effectiveness of sodium-channel activators in failing human myocardium.
    Schwinger RH; Böhm M; Mittmann C; La Rosée K; Erdmann E
    J Mol Cell Cardiol; 1991 Apr; 23(4):461-71. PubMed ID: 1658340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increase in force of contraction by activation of the Na+/Ca(2+)-exchanger in human myocardium.
    Müller-Ehmsen J; Frank K; Brixius K; Schwinger RH
    Br J Clin Pharmacol; 1997 Apr; 43(4):399-405. PubMed ID: 9146852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of inotropic interventions on the force-frequency relation in the human heart.
    Bavendiek U; Brixius K; Münch G; Zobel C; Müller-Ehmsen J; Schwinger RH
    Basic Res Cardiol; 1998; 93 Suppl 1():76-85. PubMed ID: 9833134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism underlying the reduced positive inotropic effects of the phosphodiesterase III inhibitors pimobendan, adibendan and saterinone in failing as compared to nonfailing human cardiac muscle preparations.
    von der Leyen H; Mende U; Meyer W; Neumann J; Nose M; Schmitz W; Scholz H; Starbatty J; Stein B; Wenzlaff H
    Naunyn Schmiedebergs Arch Pharmacol; 1991 Jul; 344(1):90-100. PubMed ID: 1723153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gingerol, isoproterenol and ouabain normalize impaired post-rest behavior but not force-frequency relation in failing human myocardium.
    Maier LS; Schwan C; Schillinger W; Minami K; Schütt U; Pieske B
    Cardiovasc Res; 2000 Mar; 45(4):913-24. PubMed ID: 10728417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of forskolin on the force-frequency behavior in nonfailing and end-stage failing human myocardium.
    Pieske B; Trost S; Schütt K; Minami K; Just H; Hasenfuss G
    Basic Res Cardiol; 1998; 93 Suppl 1():66-75. PubMed ID: 9833133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [In vitro and in vivo studies on the cardioprotective action of oligomeric procyanidins in a Crataegus extract of leaves and blooms].
    Chatterjee SS; Koch E; Jaggy H; Krzeminski T
    Arzneimittelforschung; 1997 Jul; 47(7):821-5. PubMed ID: 9324931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of inotropic stimulation on the negative force-frequency relationship in the failing human heart.
    Schwinger RH; Böhm M; Müller-Ehmsen J; Uhlmann R; Schmidt U; Stäblein A; Uberfuhr P; Kreuzer E; Reichart B; Eissner HJ
    Circulation; 1993 Nov; 88(5 Pt 1):2267-76. PubMed ID: 8222121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Na+-channel modulating effect of the inotropic compound S(-)BDF 9196 in human myocardium.
    Müller-Ehmsen J; Näbauer M; Schwinger RH
    Naunyn Schmiedebergs Arch Pharmacol; 1999 Jan; 359(1):60-4. PubMed ID: 9933152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of the Ca2+ sensitizers EMD 57033 and CGP 48506 on myocardial contractility and Ca2+ transients in human ventricular and atrial myocardium.
    Brixius K; Reicke S; Reuter H; Schwinger RH
    Z Kardiol; 2002 Apr; 91(4):312-8. PubMed ID: 12063703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin-like growth factor-1 exerts Ca2+-dependent positive inotropic effects in failing human myocardium.
    von Lewinski D; Voss K; Hülsmann S; Kögler H; Pieske B
    Circ Res; 2003 Feb; 92(2):169-76. PubMed ID: 12574144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced sodium pump alpha1, alpha3, and beta1-isoform protein levels and Na+,K+-ATPase activity but unchanged Na+-Ca2+ exchanger protein levels in human heart failure.
    Schwinger RH; Wang J; Frank K; Müller-Ehmsen J; Brixius K; McDonough AA; Erdmann E
    Circulation; 1999 Apr; 99(16):2105-12. PubMed ID: 10217649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enantioselective inotropic actions of the Na+-channel activators BDF 9148, BDF 9196 and BDF 9167 in human failing and nonfailing myocardium.
    Schwinger RH; Müller-Ehmsen J; Böhm M; Erdmann E
    J Pharmacol Exp Ther; 1996 Mar; 276(3):1180-8. PubMed ID: 8786551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduction of beta-adrenoceptor density and evaluation of positive inotropic responses in isolated, diseased human myocardium.
    Böhm M; Beuckelmann D; Brown L; Feiler G; Lorenz B; Näbauer M; Kemkes B; Erdmann E
    Eur Heart J; 1988 Aug; 9(8):844-52. PubMed ID: 2460351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Positive inotropic effects in isolated ventricular myocardium from non-failing and terminally failing human hearts.
    Näbauer M; Böhm M; Brown L; Diet F; Eichhorn M; Kemkes B; Pieske B; Erdmann E
    Eur J Clin Invest; 1988 Dec; 18(6):600-6. PubMed ID: 2465159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contribution of cAMP-phosphodiesterase inhibition and sensitization of the contractile proteins for calcium to the inotropic effect of pimobendan in the failing human myocardium.
    Böhm M; Morano I; Pieske B; Rüegg JC; Wankerl M; Zimmermann R; Erdmann E
    Circ Res; 1991 Mar; 68(3):689-701. PubMed ID: 1660359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inotropic effect of the cardioprotective agent 2,3-butanedione monoxime in failing and nonfailing human myocardium.
    Schwinger RH; Böhm M; Koch A; Morano I; Rüegg JC; Erdmann E
    J Pharmacol Exp Ther; 1994 May; 269(2):778-86. PubMed ID: 8182546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Na(+)-channel activators increase cardiac glycoside sensitivity in failing human myocardium.
    Schwinger RH; Böhm M; La Rosée K; Schmidt U; Schulz C; Erdmann E
    J Cardiovasc Pharmacol; 1992 Apr; 19(4):554-61. PubMed ID: 1380598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Positive inotropic effects of the novel Na+-channel modulator BDF 9198 in human nonfailing and failing myocardium.
    Müller-Ehmsen J; Brixius K; Schwinger RH
    J Cardiovasc Pharmacol; 1998 May; 31(5):684-9. PubMed ID: 9593067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.